Genor Biopharma Holdings Limited (HKG:6998)
Hong Kong
· Delayed Price · Currency is HKD 2.540
0.00 (0.00%)
Jun 6, 2025, 4:08 PM HKT
Genor Biopharma Holdings Market Cap
Genor Biopharma Holdings has a market cap or net worth of 1.32 billion as of June 6, 2025. Its market cap has increased by 124.34% in one year.
Market Cap
1.32B
Enterprise Value
198.37M
Revenue
219.46M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.54
Market Cap Chart
Since October 7, 2020, Genor Biopharma Holdings's market cap has decreased from 13.45B to 1.32B, a decrease of -90.15%. That is a compound annual growth rate of -39.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 6, 2025 | 1.32B | 48.14% |
| Dec 31, 2024 | 893.67M | 49.08% |
| Dec 29, 2023 | 599.44M | -54.84% |
| Dec 30, 2022 | 1.33B | -62.64% |
| Dec 31, 2021 | 3.55B | -63.82% |
| Dec 31, 2020 | 9.82B | -26.97% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines | 240.35B |
| Hansoh Pharmaceutical Group Company | 157.27B |
| JD Health International | 126.08B |
| Innovent Biologics | 122.48B |
| WuXi Biologics | 101.31B |
| CSPC Pharmaceutical Group | 92.00B |
| Sino Biopharmaceutical | 81.02B |
| Sichuan Kelun-Biotech Biopharmaceutical | 75.74B |